Yvonne Linney
CIK: 0001810930
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BNGO
Bionano Genomics, Inc.
Director
Discretionary Trading P&L
Holdings
About Linney Yvonne
Linney Yvonne (SEC CIK 0001810930) files insider reports with the SEC as Director of Bionano Genomics, Inc. (BNGO).
Signal8 holds 2 ownership filings by Linney Yvonne, all Form 4s, filed between Jun 12, 2025 and May 14, 2026. Those filings report 2 transactions, from Jun 11, 2025 to May 14, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Linney Yvonne's filings is in SAN DIEGO, CA.
Recent filings by Linney Yvonne
Other insiders filing for Bionano Genomics, Inc. (BNGO)
- Luderer Albert, Interim Chief Executive
- Adamchak Mark, Principal Accounting Officer
- Dixon Jonathan V., General Counsel
- OLDAKOWSKI MARK, Chief Operating Officer
- Hastie Alex Reid, Chief Scientific Officer
- Chaubey Alka, CHIEF MEDICAL OFFICER